ntroduction: Pancreatic cancer, especially Pancreatic Adenocarcinoma, is still associated with a high mortality and morbidity for affected patients notwithstanding considerable progresses in diagnosis and both surgical pharmacological therapy. Despite metastases from colorectal, gastric and neuroendocrine primary tumor and their treatment are widely reported, the literature has been rarely investigated the impact of localization and numbers of pancreatic metastases. This study performed a systematic analysis of the most recent scientific literature on the natural history of Pancreatic Adenocarcinoma focusing attention on the role that the “M” parameter has on a possible prognostic stratification of these patients. Material and Methods: PubM...
Introduction: The relation between the primary origin of metastasised pancreatic ductal adenocarcino...
Pancreatic cancers are associated with poor survival and only some 10 per cent are resectable, but e...
Although metastasis is a major cause of morbidity and mortality in patients with pancreatic cancer, ...
Pancreatic cancer, especially Pancreatic Adenocarcinoma, is still associated with a high mortality a...
The real impact of specific sites of metastasis on prognosis of metastatic pancreatic cancer (MPC) i...
SummaryPancreatic cancer is a leading cause of cancer-related death, largely due to metastatic disse...
Although rare, metastases to the pancreas from other primary tumors are increasingly recognized in c...
Pancreatic metastases from renal cell carcinoma are uncommon and their prognostic significance is no...
Pancreatic metastases (PMs) from neuroendocrine neoplasms (NENs) are rare but the increased sensitiv...
BACKGROUND AND OBJECTIVES: The incidence of metastases to the pancreas is very low. The benefit of r...
Pancreatic metastases from other primary malignancies are a rare entity. By far, the most common pri...
Background: Metastases to the pancreas are rare, accounting for less then 2 % of all pancreatic mali...
OBJECTIVES: Patients with pancreatic adenocarcinoma often present with distant metastatic diseas...
INTRODUCTION: Metastases to the pancreas from other primary tumors are increasingly recognized in ...
Introduction: The relation between the primary origin of metastasised pancreatic ductal adenocarcino...
Introduction: The relation between the primary origin of metastasised pancreatic ductal adenocarcino...
Pancreatic cancers are associated with poor survival and only some 10 per cent are resectable, but e...
Although metastasis is a major cause of morbidity and mortality in patients with pancreatic cancer, ...
Pancreatic cancer, especially Pancreatic Adenocarcinoma, is still associated with a high mortality a...
The real impact of specific sites of metastasis on prognosis of metastatic pancreatic cancer (MPC) i...
SummaryPancreatic cancer is a leading cause of cancer-related death, largely due to metastatic disse...
Although rare, metastases to the pancreas from other primary tumors are increasingly recognized in c...
Pancreatic metastases from renal cell carcinoma are uncommon and their prognostic significance is no...
Pancreatic metastases (PMs) from neuroendocrine neoplasms (NENs) are rare but the increased sensitiv...
BACKGROUND AND OBJECTIVES: The incidence of metastases to the pancreas is very low. The benefit of r...
Pancreatic metastases from other primary malignancies are a rare entity. By far, the most common pri...
Background: Metastases to the pancreas are rare, accounting for less then 2 % of all pancreatic mali...
OBJECTIVES: Patients with pancreatic adenocarcinoma often present with distant metastatic diseas...
INTRODUCTION: Metastases to the pancreas from other primary tumors are increasingly recognized in ...
Introduction: The relation between the primary origin of metastasised pancreatic ductal adenocarcino...
Introduction: The relation between the primary origin of metastasised pancreatic ductal adenocarcino...
Pancreatic cancers are associated with poor survival and only some 10 per cent are resectable, but e...
Although metastasis is a major cause of morbidity and mortality in patients with pancreatic cancer, ...